AzTrials
AzTrials

StrokeNCT07494487

Reliability of Community Ambulation Ability, Fall Risk, and Dynamic Visual Acuity Assessments in Stroke

An observational study of Stroke, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Nearly half of individuals with stroke experience limitations in community ambulation, and 35.7% of community-dwelling stroke survivors experienced falls while walking, indicating that falls are common during routine daily activities in community settings. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
How many people
30 participants
Where
1 siteTaiwan
Study dates
1 Apr 2026to 31 Jul 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Individuals with chronic stroke

Who may be able to join

  • Diagnosis of First-occurrenced stroke
  • ≥ 6 months after stroke
  • Ability to walk at least 400 meters with or without the use of a walking assistive device
  • Mini-Mental State Examination score ≥ 24
  • Age between 18 and 80 years

Who cannot join

  • Other neurological or musculoskeletal conditions affected postural stability
  • Presence of dizziness or vertigo
  • Presence of conditions affecting cervical blood flow or limiting cervical range of motion
  • Visual impairment
  • Unstable cardiac status or uncontrolled hypertension

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yea-Ru Yang, PhD contact

+886228267279

yryang@nycu.edu.tw

Taiwan1 site
  • Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University

    Taipei, 112

    Yea-Ru Yang, PhD, +886-2-2826-7279, yryang@nycu.edu.tw

Other trials in Taiwan

About this study

Official title: Reliability of Community Ambulation Assessments, Taiwan Chinese Version of Falls Efficacy Scale, and Dynamic Visual Acuity Test in Individuals With Chronic Stroke

Nearly half of individuals with stroke experience limitations in community ambulation, and 35.7% of community-dwelling stroke survivors experienced falls while walking, indicating that falls are common during routine daily activities in community settings. Patla (1999) proposed that community mobility is influenced by eight factors: ambient conditions, terrain characteristics, external physical load, attentional demands, postural transitions, traffic level, time constraints, and walking distance. This framework suggests that community ambulation requires consideration of multiple physiological domains as well as environmental factors. However, current assessments of community ambulation primarily rely on indoor walking speed as an indicator, which may be insufficient to fully evaluate patients' community ambulation ability. Previous studies have not yet established the reliability of community ambulation assessments such as the Walking Ability Questionnaire, community walking speed, and the Falls Efficacy Scale (Taiwan Chinese version)-in individuals with chronic stroke. Additionally, stroke survivors often demonstrate insufficient integration of vestibular information, which may affect gait performance through impaired dynamic visual acuity. Therefore, this study aims to investigate the reliability of community ambulation assessments and dynamic visual acuity testing in individuals with chronic stroke.

Conditions
Stroke
Keywords
fall risk, community ambulation, stroke, dynamic acuity, reliability
Medical subject headings
Stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Walking Ability Questionnaire

    Walking Ability Questionnaire consisting of 19 items related to daily walking activities to assess community ambulation

    Measured: The test will be conducted twice, with the second session scheduled 3-10 days after the first session

  2. Community Walking Speed

    Participants will complete an approximately 400-meter walking task

    Measured: The test will be conducted twice, with the second session scheduled 3-10 days after the first session

  3. Taiwan Chinese Version of the Falls Efficacy Scale

    Participants will rate their level of concern about falling while performing 16 activities using a 4-point Likert scale to evaluate fall risk

    Measured: The test will be conducted twice, with the second session scheduled 3-10 days after the first session

  4. Dynamic Visual Acuity Test

    Using Dynamic Visual Acuity Test to evaluate vestibulo-ocular reflex function

    Measured: The test will be conducted twice, with the second session scheduled 3-10 days after the first session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2026
  2. Study start1 Apr 2026 (estimated)
  3. Primary completion31 Jul 2028 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07494487
Sponsor's protocol ID
NYCU114245AF1
Status last verified
Mar 2026
First submitted
20 Mar 2026
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by National Yang Ming Chiao Tung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yea-Ru Yang, PhD (+886228267279, yryang@nycu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Walking Ability Questionnaire (time frame: The test will be conducted twice, with the second session scheduled 3-10 days after the first session). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in